Expression of the immunoproteasome subunit β5i in non-small cell lung carcinomas

Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma

(2020) Shelly Kalaora et al.   Nature Communications

Expression of Immunoproteasome Subunit LMP7 in Breast Cancer and Its Association with Immune-Related Markers

(2018) Miseon Lee et al.   Cancer Research and Treatment

Immune checkpoint inhibitors for nonsmall cell lung cancer treatment

(2017) Yuh-Min Chen   Journal of the Chinese Medical Association

Impairment of Immunoproteasome Function by Cigarette Smoke and in Chronic Obstructive Pulmonary Disease

(2016) Ilona E. Kammerl et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Gene aberrations for precision medicine against lung adenocarcinoma

(2016) Motonobu Saito et al.   CANCER SCIENCE

Emerging role of immunoproteasomes in pathophysiology

(2016) Gagandeep Kaur et al.   IMMUNOLOGY AND CELL BIOLOGY

Trends and advances in tumor immunology and lung cancer immunotherapy

(2016) Mohanad Aldarouish et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

(2016) Peter Goldstraw et al.   Journal of Thoracic Oncology

New and emerging targeted treatments in advanced non-small-cell lung cancer

(2016) Fred R Hirsch et al.   LANCET

Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome

(2016) Satyendra C. Tripathi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Expression of immunoproteasome genes is regulated by cell-intrinsic and –extrinsic factors in human cancers

(2016) Alexandre Rouette et al.   Scientific Reports

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Expression of Fucosyltransferase 8 Is Associated with an Unfavorable Clinical Outcome in Non-Small Cell Lung Cancers

(2015) Rio Honma et al.   ONCOLOGY

Putative effectors for prognosis in lung adenocarcinoma are ethnic and gender specific

(2015) Andrew Woolston et al.   Oncotarget

Regulation of Immunoproteasome Function in the Lung

(2015) Ilona E. Keller et al.   Scientific Reports

Human Tumor Antigens and Cancer Immunotherapy

(2015) Nathalie Vigneron   Biomed Research International

New Insights into the Function of the Immunoproteasome in Immune and Nonimmune Cells

(2015) Hiroaki Kimura et al.   Journal of Immunology Research

Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to Smoking History

(2014) A. Karlsson et al.   CLINICAL CANCER RESEARCH

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

Tumor immunosurveillance in human cancers

(2011) Bernhard Mlecnik et al.   CANCER AND METASTASIS REVIEWS

Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives

(2011) D. Chen et al.   CURRENT CANCER DRUG TARGETS

Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction

(2011) Bernhard Mlecnik et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer

(2011) Sahar M.A. Mahmoud et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical development of novel proteasome inhibitors for cancer treatment

(2009) Huanjie Yang et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

The proteasome: Overview of structure and functions

(2009) Keiji TANAKA   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

Predominant infiltration of macrophages and CD8+T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer

(2008) Osamu Kawai et al.   CANCER

Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non-Small Cell Lung Cancer

(2008) K. I. Al-Shibli et al.   CLINICAL CANCER RESEARCH

Rapid Activation of Stat3 and ERK1/2 by Nicotine Modulates Cell Proliferation in Human Bladder Cancer Cells

(2008) Rong-Jane Chen et al.   TOXICOLOGICAL SCIENCES